News EUMDR grants Huma expansive IIb classification Huma has received Class IIb certification from the EUMDR for a disease-agnostic SAMD.
News Jeito closes 'record' $1.2bn Europe-focused biopharma fund Jeito Capital has closed its second fund, raking in €1bin, which it claims is the largest ever raise for an independent European biopharma fund.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
